Commenting on the study for heartwire, antiplatelet expert Dr Victor Serebruany (HeartDrug Research, Towson, MD) said: "This is an extremely important paper with a clear clinical message—abrupt ...
A research team has demonstrated that clopidogrel is more effective than aspirin as a long-term antiplatelet therapy in ...
In January 2008, Dr Steven Steinhubl announced that he was leaving his academic position to join The Medicines Company. Although Steinhubl had no official relationship with the company at the time he ...
In patients who develop a hypersensitivity reaction to clopidogrel soon after stenting, a short course of oral corticosteroids usually allows them to continue the antiplatelet therapy without ...
For decades, aspirin has been the go‑to drug for preventing heart attacks and strokes. But recent research is turning that assumption on its head. Aspirin has been overtaken by another well-known ...
People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel ...
New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.
In patients with ST-segment elevation myocardial infarction (STEMI), administering clopidogrel prior to their arrival at the facility where they will receive percutaneous coronary intervention (PCI) ...
Background A 67-year-old man with supraventricular tachycardia associated with angina underwent coronary angiographic assessment. This investigation revealed mild coronary artery disease in his left ...
Researchers at 37 sites in South Korea have found patients taking clopidogrel after percutaneous coronary intervention (PCI) experienced lower rates of both thrombotic and bleeding events than those ...
Despite current treatments, patients who have acute coronary syndromes without ST-segment elevation have high rates of major vascular events. We evaluated the efficacy and safety of the antiplatelet ...
Gaspoz et al. (June 6 issue) 1 present an interesting perspective on the problem of escalating health care costs. Their comparison between the cost effectiveness of aspirin and that of clopidogrel is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results